Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
Atrial Fibrillation
About this trial
This is an interventional prevention trial for Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria:
- Adult patients 18 and older seen in Massachusetts General Hospital primary care practices in the past 3 years
- Diagnosed with atrial fibrillation
- Increased risk of stroke (CHA2DS2VASc score ≥ 2)
- Not currently taking an anticoagulant
Exclusion Criteria:
- Patients who are subsequently identified as having died prior to or during the course of the study intervention using the Social Security Death Index
- Listed in the Massachusetts General Hospital system as having a PCP outside of the network
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Baseline alert
3-month alert arm
For patients randomly selected for the baseline alert arm, their physicians will be alerted via email that a patient(s) under their care has atrial fibrillation, is at high risk of stroke, and is not currently anticoagulated. Physicians will also be asked to complete a survey related to anticoagulation for each patient and will be provided with educational resources and consultation services.
For patients randomly selected for the 3-month alert arm, their physicians will not be notified during the 3-month study follow-up period. Instead, PCPs will be sent alerts after 3-months via email for these patients.